No Data
No Data
B.Riley Financial Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Raises Target Price to $2
Director Makes Bold Move With Major Stock Purchase in Cognition Therapeutics
Insider Purchase: CEO & President of $CGTX Buys 38,851 Shares
Express News | Cognition’s Positive Phase 2 ‘Shimmer’ Study of Zervimesine (Ct1812) in Dementia With Lewy Bodies (Dlb) Will Be Presented in a Podium Presentation at Ilbdc
Cognition's Positive Phase 2 'SHIMMER' Study of Zervimesine (CT1812) in Dementia With Lewy Bodies (DLB) Will Be Presented in a Podium Presentation at ILBDC
Cognition Therapeutics Shows Promising Phase 2 Study Results
iluvpoptarts : ty much. I owe you a good joke when you're ready
manukahoney : when will CCTG pump occur? pre market today?
Jaguar8 OP manukahoney : it already started pumping Friday AH
manukahoney Jaguar8 OP : is it too late if i pump today during pre market sir?